Article Details
Retrieved on: 2021-11-30 20:19:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A devastating trial flop for its gastrointestinal cancer drug Qinlock has prompted Deciphera to undergo a transformation. The biopharma will cut ...
Article found on: www.fiercepharma.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here